Philippe Fauchet
Directeur/Bestuurslid bij REZOLUTE, INC.
Vermogen: - $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Philippe Fauchet
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom.
17
| Holding Company | Investment Managers | 17 |
| Public Company | Pharmaceuticals: Major | 17 | |
GlaxoSmithKline KK
 GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan
7
| Subsidiary | Household/Personal Care | 7 |
| Public Company | Pharmaceuticals: Major | 3 | |
Luca Science, Inc.
 Luca Science, Inc. BiotechnologyHealth Technology Luca Science, Inc. is a Japanese preclinical stage biopharmaceutical company that specializes in mitochondrial therapy to restore cellular bioenergetics in dysfunctional or damaged tissues and organs. Luca Science is based in Chuo-ku, JP, and was founded in December 2018 by Masashi Suganuma. The company uses its platform technology to manufacture, store, and deliver innovative mitochondrial drugs to research and develop therapeutics for unmet medical needs in a wide range of diseases for which there have been no effective treatments. The CEO is Rick C. Tsai.
2
| Holding Company | Biotechnology | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Philippe Fauchet via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| The Salk Institute for Biological Studies | College/University | Director/Board Member | |
| University of Notre Dame | College/University | Undergraduate Degree | |
RetroSense Therapeutics LLC
 RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Director/Board Member | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Investment Officer Corporate Officer/Principal Corporate Officer/Principal | |
HSBC Investment Bank Plc
 HSBC Investment Bank Plc Regional BanksFinance Part of HSBC Holdings Plc, HSBC Investment Bank Plc provides stock broking services. The company is based in London, UK. | Regional Banks | Corporate Officer/Principal | |
| TOTETSU KOGYO CO., LTD. | Engineering & Construction | Director/Board Member | |
| University of Oxford | College/University | Graduate Degree Graduate Degree | |
Wilson Sonsini Goodrich & Rosati PC
 Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Indiana University | College/University | Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Doctorate Degree | |
| University of Bridgeport | College/University | Undergraduate Degree | |
| Santa Clara University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Masters Business Admin | |
| University of Montréal | College/University | Undergraduate Degree | |
| Moscow State University Lomonosov | College/University | Undergraduate Degree | |
| State University of St. Petersburg | College/University | Undergraduate Degree | |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| E2OPEN INC | Packaged Software | Founder Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Sherbrooke | College/University | Masters Business Admin | |
| University of Hamburg | College/University | Undergraduate Degree | |
| Yonsei University | College/University | Undergraduate Degree Undergraduate Degree | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Montréal International
 Montréal International Miscellaneous Commercial ServicesCommercial Services Montréal International attracts and promotes economic development of Greater Montreal. The company was founded in 1996 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Bend Research, Inc.
 Bend Research, Inc. Pharmaceuticals: MajorHealth Technology Bend Research, Inc. provides drug delivery and formulation development technologies. The company is headquartered in Bend, OR. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vascular Flow Technologies Ltd.
 Vascular Flow Technologies Ltd. Electronic Equipment/InstrumentsElectronic Technology Vascular Flow Technologies Ltd. develops vascular devices. It offers Spiral Flow Peripheral Vascular Graft, Spiral Flow AV Access Graft, Spiral Laminar Flow, Power of Spiral Laminar Flow and unique design eliminates graft turbulences. The company was founded by Peter Stonebridge, Brian Howlett, Graeme Houston and John B.C. Dick and headquartered in Dundee, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
| GENEXINE, INC. | Biotechnology | Director/Board Member Founder | |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
UltraSoC Technologies Ltd.
 UltraSoC Technologies Ltd. Packaged SoftwareTechnology Services UltraSoC Technologies Ltd. engages in the development of debugging technology for the embedded electronic systems. It offers semiconductor IP for on-chip analytics, performance optimization, and hardware-based security. The company was founded by Stephen Karl Heeks, Andrew Brian Thomas Hopkins, and Klaus Dieter McDonald-Maier in 2006 and is headquartered in Cambridge, the United Kingdom. | Packaged Software | Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Enso Ventures Ltd.
 Enso Ventures Ltd. Investment ManagersFinance Enso Ventures Ltd (Enso Ventures) is an independent venture capital firm founded in 2010 by Nikolay Danilov. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal Private Equity Investor Director of Finance/CFO | |
Agere Pharmaceuticals, Inc.
 Agere Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Agere is a leading contract development and manufacturing organization (CDMO) providing pre-clinical formulation development through clinical-stage cGMP manufacturing services for drug products. They specialize in improving the oral bioavailability of BCS II – IV compounds through fundamental science, solubilisation expertise, and proprietary solubilisation technologies. Their formulation services leverage Agere’s Quadrant 2™ design platform, which encapsulates fundamental science, extensive expertise and best practices to achieve a faster path to bioavailability enhancement. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Japan Vaccine Co., Ltd.
 Japan Vaccine Co., Ltd. BiotechnologyHealth Technology Japan Vaccine Co., Ltd. develops and markets preventive vaccines. The joint venture company is based in Tokyo, Japan. | Biotechnology | President | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
pH Pharma Co., Ltd.
 pH Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology pH Pharma Co. Ltd. engages in the developing and manufacturing of bio-pharmaceuticals. Its products include php-303, php-201, ab-101, nuvesse, alpine and torpedo products. The company was founded by Ho Young Huh on September 22, 2015 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
| JCR USA, Inc. | Director/Board Member Chief Executive Officer | ||
Araris Biotech AG
 Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
| Pancreas Research Foundation of Japan | Chairman | ||
Code Biotherapeutics, Inc.
 Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member Chief Executive Officer | |
Locki Therapeutics Ltd.
 Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Hornet Therapeutics Ltd.
 Hornet Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Hornet Therapeutics Ltd. is a British company founded in 2019 that provides immune cell metabolism and cell therapy for cancer treatment. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ray Therapeutics, Inc.
 Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 26 |
| Verenigd Koninkrijk | 10 |
| Japan | 5 |
| Canada | 5 |
| Zuid-Korea | 4 |
Sectoraal
| Health Technology | 20 |
| Consumer Services | 16 |
| Commercial Services | 8 |
| Finance | 3 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 109 |
| Corporate Officer/Principal | 70 |
| Undergraduate Degree | 28 |
| President | 23 |
| Chief Executive Officer | 21 |
Sterkste connecties
| Insiders | |
|---|---|
| Nevan Elam | 16 |
| Marc Dunoyer | 16 |
| Daron Evans | 15 |
| Young-Jin Kim | 15 |
| Susan Stewart | 15 |
| Gil Labrucherie | 15 |
| Brian McVeigh | 15 |
| Nerissa Kreher | 13 |
| Andrey Kozlov | 12 |
| Wladimir Hogenhuis | 10 |
| Kieran Mudryy | 10 |
| Eric Dube | 10 |
| Toshihide Yoda | 10 |
| Young-Chul Sung | 9 |
| Keith Vendola | 9 |
- Beurs
- Insiders
- Philippe Fauchet
- Bedrijfsconnecties
